Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285678625> ?p ?o ?g. }
- W4285678625 endingPage "182" @default.
- W4285678625 startingPage "175" @default.
- W4285678625 abstract "A novel prognostic model was recommended for patients with metastatic RCC (mRCC) by the International mRCC Database Consortium (IMDC). In this study, we aimed to externally validate a novel risk model for the IMDC-favorable risk group in patients with mRCC.The Turkish Oncology Group Kidney Cancer Consortium (TKCC) is a multicenter registry that includes 13 cancer centers in Turkey. As described by Schmidt et al., 3 parameters (ie, time from diagnosis to systemic therapy <3 vs. ≥3 years, Karnofsky Performance Status [KPS] 80 vs. >80, and the presence of brain, liver, or bone metastasis) were used to divide the IMDC favorable risk group into 2 new categories: very favorable and favorable risk groups. The primary endpoint was overall survival (OS). Time to treatment failure (TTF) and objective response rate (ORR) in the very favorable and favorable risk groups were the secondary endpoints.A total of 545 patients with mRCC from all IMDC risk groups and 112 patients from the favorable risk group were included in this study. According to the novel classification model, 44 (39.3%) and 68 (60.7%) patients with former favorable risk were categorized into very favorable and favorable risk groups, respectively. The median OS (55.8 months vs. 34.2 months, P = .025) and TTF (25.5 months vs. 15.5 months, P = .010) were longer in the very favorable risk group than in the favorable risk group. The concordance index of the new IMDC model in all patients was 0.65 for OS. Despite the higher ORR in the very favorable risk group than in the favorable risk group, the difference between the groups was not statistically significant (52.4% vs. 44.7, P = .573).This was the first study to externally validate the novel IMDC risk model presented in the American Society of Clinical Oncology Genitourinary Cancers Symposium 2021." @default.
- W4285678625 created "2022-07-17" @default.
- W4285678625 creator A5001724116 @default.
- W4285678625 creator A5012135670 @default.
- W4285678625 creator A5013823331 @default.
- W4285678625 creator A5013941417 @default.
- W4285678625 creator A5019461247 @default.
- W4285678625 creator A5023874099 @default.
- W4285678625 creator A5027860268 @default.
- W4285678625 creator A5028500628 @default.
- W4285678625 creator A5029566579 @default.
- W4285678625 creator A5033323622 @default.
- W4285678625 creator A5056164245 @default.
- W4285678625 creator A5056352422 @default.
- W4285678625 creator A5058897783 @default.
- W4285678625 creator A5059941445 @default.
- W4285678625 creator A5062129196 @default.
- W4285678625 creator A5063630319 @default.
- W4285678625 creator A5064592414 @default.
- W4285678625 creator A5067436525 @default.
- W4285678625 creator A5071613646 @default.
- W4285678625 creator A5083927273 @default.
- W4285678625 creator A5084659231 @default.
- W4285678625 date "2023-02-01" @default.
- W4285678625 modified "2023-10-16" @default.
- W4285678625 title "External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium (IMDC): Results From the Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database" @default.
- W4285678625 cites W2015054022 @default.
- W4285678625 cites W2099752220 @default.
- W4285678625 cites W2108606306 @default.
- W4285678625 cites W2113322173 @default.
- W4285678625 cites W2405973840 @default.
- W4285678625 cites W2484090454 @default.
- W4285678625 cites W2757487320 @default.
- W4285678625 cites W2911812451 @default.
- W4285678625 cites W2913500231 @default.
- W4285678625 cites W2943887705 @default.
- W4285678625 cites W2985979810 @default.
- W4285678625 cites W3093923068 @default.
- W4285678625 cites W3131063362 @default.
- W4285678625 cites W3134949580 @default.
- W4285678625 cites W3135745963 @default.
- W4285678625 cites W3210028029 @default.
- W4285678625 doi "https://doi.org/10.1016/j.clgc.2022.07.006" @default.
- W4285678625 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35970759" @default.
- W4285678625 hasPublicationYear "2023" @default.
- W4285678625 type Work @default.
- W4285678625 citedByCount "1" @default.
- W4285678625 countsByYear W42856786252023 @default.
- W4285678625 crossrefType "journal-article" @default.
- W4285678625 hasAuthorship W4285678625A5001724116 @default.
- W4285678625 hasAuthorship W4285678625A5012135670 @default.
- W4285678625 hasAuthorship W4285678625A5013823331 @default.
- W4285678625 hasAuthorship W4285678625A5013941417 @default.
- W4285678625 hasAuthorship W4285678625A5019461247 @default.
- W4285678625 hasAuthorship W4285678625A5023874099 @default.
- W4285678625 hasAuthorship W4285678625A5027860268 @default.
- W4285678625 hasAuthorship W4285678625A5028500628 @default.
- W4285678625 hasAuthorship W4285678625A5029566579 @default.
- W4285678625 hasAuthorship W4285678625A5033323622 @default.
- W4285678625 hasAuthorship W4285678625A5056164245 @default.
- W4285678625 hasAuthorship W4285678625A5056352422 @default.
- W4285678625 hasAuthorship W4285678625A5058897783 @default.
- W4285678625 hasAuthorship W4285678625A5059941445 @default.
- W4285678625 hasAuthorship W4285678625A5062129196 @default.
- W4285678625 hasAuthorship W4285678625A5063630319 @default.
- W4285678625 hasAuthorship W4285678625A5064592414 @default.
- W4285678625 hasAuthorship W4285678625A5067436525 @default.
- W4285678625 hasAuthorship W4285678625A5071613646 @default.
- W4285678625 hasAuthorship W4285678625A5083927273 @default.
- W4285678625 hasAuthorship W4285678625A5084659231 @default.
- W4285678625 hasConcept C112930515 @default.
- W4285678625 hasConcept C126322002 @default.
- W4285678625 hasConcept C143998085 @default.
- W4285678625 hasConcept C160798450 @default.
- W4285678625 hasConcept C168563851 @default.
- W4285678625 hasConcept C203092338 @default.
- W4285678625 hasConcept C2777472916 @default.
- W4285678625 hasConcept C2781068499 @default.
- W4285678625 hasConcept C2986432223 @default.
- W4285678625 hasConcept C71924100 @default.
- W4285678625 hasConceptScore W4285678625C112930515 @default.
- W4285678625 hasConceptScore W4285678625C126322002 @default.
- W4285678625 hasConceptScore W4285678625C143998085 @default.
- W4285678625 hasConceptScore W4285678625C160798450 @default.
- W4285678625 hasConceptScore W4285678625C168563851 @default.
- W4285678625 hasConceptScore W4285678625C203092338 @default.
- W4285678625 hasConceptScore W4285678625C2777472916 @default.
- W4285678625 hasConceptScore W4285678625C2781068499 @default.
- W4285678625 hasConceptScore W4285678625C2986432223 @default.
- W4285678625 hasConceptScore W4285678625C71924100 @default.
- W4285678625 hasIssue "1" @default.
- W4285678625 hasLocation W42856786251 @default.
- W4285678625 hasLocation W42856786252 @default.
- W4285678625 hasOpenAccess W4285678625 @default.
- W4285678625 hasPrimaryLocation W42856786251 @default.
- W4285678625 hasRelatedWork W2068230073 @default.
- W4285678625 hasRelatedWork W2415433510 @default.
- W4285678625 hasRelatedWork W2551353941 @default.